Peter Bold is an author at AstraZeneca (Sweden) specializing in medicine, pharmacology, and pre-clinical pharmacology.
Top concepts
MedicineImmunologyBiochemistryPharmacologyDrug DiscoveryPharmacotherapyDrug DevelopmentNatural SciencesLung InflammationMedicinal Chemistry
Publications per year
2010–2021
3
3
Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma
Matthew W. D. Perry, Karin Björhall, Peter Bold et al. · Journal of Medicinal Chemistry · 2021 · 34 citations · Full text
Rows per page
1–3 of 3